Table 3.
Risk of healthy vaccinee bias and confounding by indication in the included studies, as judged from the baseline characteristics of vaccinated and unvaccinated participants
| Study | Healthy vaccinee biasa | Confounding by indicationb | Indicated by |
|---|---|---|---|
| Bond et al. (2012) [17] |
|
|
Vaccinated participants have more comorbidities; unvaccinated have worse laboratory values |
| Campitelli et al. (2011) [7] |
|
|
Vaccinated participants have more comorbidities; unvaccinated patients have worse functional status |
| Foster et al. (1992) [18] |
|
|
More comorbidities in vaccinated participants |
| France et al. (2006) [34] |
|
|
More comorbidities in vaccinated participants |
| Groenwold et al. (2009) [19] |
|
|
More comorbidities, medications and medical visits in vaccinated participants |
| Hottes et al. (2011) [20] |
|
|
More medical visits in vaccinated participants |
| Jackson et al. (2002) [21] |
|
|
More comorbidities in vaccinated participants |
| Jackson et al. (2006) [3] |
|
|
More comorbidities in vaccinated participants |
| Jackson et al. (2008) [5] |
|
|
No major differences in baseline characteristics between groups |
| Johnstone et al. (2012) [33] |
|
|
Vaccinated participants have more CAD; unvaccinated have more diabetes and hypertension |
| Liu et al. (2012) [22] |
|
|
More comorbidities in vaccinated participants |
| Mangtani et al. (2004) [16] |
|
|
More comorbidities and medications in vaccinated participants |
| McGrath et al. (2012) [23] |
|
|
Better adherence to dialysis and fewer years with end-stage renal disease in vaccinated participants |
| Nichol et al. (2008) [24] |
|
|
More comorbidities in vaccinated participants |
| Nichol et al. (2009) [25] |
|
|
No major differences in baseline characteristics between groups |
| Ohmit et al. (1995) [26] |
|
|
Unclear data and description |
| Omer et al. (2011) [27] |
|
|
Some comorbidities different (diabetes) between groups, other not (hypertension) |
| Örtqvist et al. (2007) [15] |
|
|
More comorbidities in vaccinated participants |
| Schembri et al. (2009) [28] |
|
|
More comorbidities in vaccinated participants |
| Sung et al. (2014) [29] |
|
|
More comorbidities in unvaccinated participants |
| Tessmer et al. (2011) [30] |
|
|
More comorbidities in vaccinated participants |
| Villa-Corcoles et al. (2007) [31] |
|
|
More comorbidities in vaccinated participants |
| Wong et al. (2012) [32] |
|
|
More comorbidities and medications in vaccinated participants |
green circle/+: low risk of bias; red circle/-: high risk of bias; yellow circle/?: unclear risk of bias; CAD, coronary artery disease
aindicated by: vaccinated participants were healthier (fewer comorbidities) than unvaccinated participants at study entry (cohort studies) or vaccinated controls were healthier (fewer comorbidities) than unvaccinated controls (case–control studies)
bindicated by: vaccinated participants were sicker (more comorbidities) than unvaccinated participants at study entry (cohort studies) or vaccinated controls were sicker (more comorbidities) than unvaccinated controls (case–control studies)